Who Owns Acrivon Therapeutics, Inc. Common Stock (ACRV)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$5.11500030000002e+113T
% of Float Held
9.558821574498323e+238%
QoQ Change in Holders
+11 / -5
Price History
ACRV — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | Increased | +266K | +$422.2M |
| CITADEL ADVISORS LLC | Increased | +101K | +$210.2M |
| Vermillion & White Wealth Management Group, LLC | New Position | +18K | +$43.0M |
| NISA INVESTMENT ADVISORS, LLC | New Position | +584 | +$1.0M |
| ACADIAN ASSET MANAGEMENT LLC | Increased | +489K | +$835K |
| Schonfeld Strategic Advisors LLC | New Position | +16K | +$39K |
| FEDERATED HERMES, INC. | New Position | +6K | +$0 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | +6K | +$0 |
| PRELUDE CAPITAL MANAGEMENT, LLC | New Position | +48K | +$0 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | +12K | +$0 |
| Point72 Asset Management, L.P. | New Position | +11K | +$0 |
| Quadrature Capital Ltd | New Position | +21K | +$0 |
| SBI Securities Co., Ltd. | New Position | +74 | +$0 |
| Marex Group plc | New Position | +10K | +$0 |
| OPTIMA CAPITAL LLC | New Position | +278 | +$0 |
ACRV — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| Focus Partners Wealth | Closed Position | -20K | -$987.9M |
| UBS Group AG | Decreased | -335K | -$397.6M |
| MILLENNIUM MANAGEMENT LLC | Decreased | -64K | -$335.3M |
| Squarepoint Ops LLC | Decreased | -78K | -$188.8M |
| XTX Topco Ltd | Decreased | -15K | -$65.1M |
| DIMENSIONAL FUND ADVISORS LP | Decreased | -1K | -$35.5M |
| CITIGROUP INC | Decreased | -2K | -$29.5M |
| Tower Research Capital LLC (TRC) | Closed Position | -9K | -$15.8M |
| GF FUND MANAGEMENT CO. LTD. | Closed Position | -650 | -$1.2M |
| BlackRock, Inc. | Decreased | -126K | -$597K |
| MORGAN STANLEY | Decreased | -10K | -$102K |
| ALGERT GLOBAL LLC | Closed Position | -45K | -$81K |
| BANK OF AMERICA CORP /DE/ | Decreased | -1K | -$34K |
| China Universal Asset Management Co., Ltd. | Closed Position | -6K | -$9K |
| BNP PARIBAS FINANCIAL MARKETS | Decreased | -555 | -$2K |
Top Institutional Holders(Q4 2025)
ACRV Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 48 | $14.1B | +6 |
| Q3 2025 | 42 | $30.0B | +0 |
| Q2 2025 | 42 | $14.9B | -20 |
| Q1 2025 | 62 | $43.8B | +1 |
| Q4 2024 | 61 | $125.5B | +10 |
| Q3 2024 | 51 | $944.1B | +0 |
| Q2 2024 | 51 | $1.1T | +8 |
| Q1 2024 | 43 | $1.1T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold ACRV (Acrivon Therapeutics, Inc. Common Stock). The largest holder is Sands Capital Alternatives, LLC with $5.1B in shares. This quarter, 11 institutions opened new positions and 5 closed their positions.
Frequently Asked Questions
How many hedge funds own ACRV?
As of Q4 2025, 50 institutional investors report holding ACRV (Acrivon Therapeutics, Inc. Common Stock) in their 13F filings.
Who is the largest institutional holder of ACRV?
The largest institutional holder of ACRV is Sands Capital Alternatives, LLC with $5.1B in shares.
Is institutional ownership of ACRV increasing or decreasing?
This quarter, 11 institutions opened new positions in ACRV and 5 closed their positions.